...
首页> 外文期刊>Morbidity and mortality weekly report >Update: Creutzfeldt-Jakob disease associated with cadaveric dura mater grafts--Japan, 1978-2008.
【24h】

Update: Creutzfeldt-Jakob disease associated with cadaveric dura mater grafts--Japan, 1978-2008.

机译:更新:1978年至2008年,日本与尸体硬脑膜移植物相关的Creutzfeldt-Jakob病。

获取原文
获取原文并翻译 | 示例
           

摘要

Creutzfeldt-Jakob disease (CJD) is the most common of the human prion diseases (also known as transmissible spongiform encephalopathies), which, according to the leading hypothesis, are caused by an abnormal protein (i.e., prion) that is able to induce abnormal folding of normal cellular prion proteins. Annual worldwide incidence of these always fatal neurodegenerative diseases is estimated at 0.5-2.0 cases per million population. CJD can occur sporadically, or as a genetic disease, or can be transmitted iatrogenically. In 1996, a new human prion disease, variant CJD (vCJD), was first described in the United Kingdom. This disease was believed to have resulted from human consumption of cattle products contaminated with the prions responsible for bovine spongiform encephalopathy (BSE, commonly known as mad cow disease). That year, in part to check for possible vCJD cases, a national survey was conducted in Japan; 821 CJD cases were identified, including 43 cases associated with receipt of cadaveric dura mater grafts. A single brand of dural graft (Lyodura) produced by a German manufacturer before May 1987 was identified as the most likely vehicle of transmission in all but one case. By 2003, continued surveillance in Japan had identified a total of 97 such cases. Since then, an additional 35 cases have been identified. This report updates previous reports and summarizes the investigation of all 132 cases to date linked to dural grafts. The results suggest that, because of the long incubation period between graft receipt and symptom onset (possibly >24.8 years), continued surveillance in Japan might identify additional CJD cases associated with dural grafts.
机译:Creutzfeldt-Jakob病(CJD)是人类pr病毒病中最常见的疾病(也称为传染性海绵状脑病),根据主要假设,该病是由能够诱导异常的异常蛋白质(即病毒)引起的。正常细胞病毒蛋白的折叠。这些致命性神经退行性疾病的全球年度发病率估计为每百万人口0.5-2.0例。 CJD可以偶发或作为遗传性疾病发生,或可以通过医源性传播。 1996年,在英国首次描述了一种新的人类病毒病,变异CJD(vCJD)。人们认为这种疾病是由于人类食用了被造成牛海绵状脑病(BSE,通常称为疯牛病)的the病毒污染的牛产品。那年,部分检查了可能的vCJD病例,在日本进行了一次全国性调查。确定了821例CJD病例,其中43例与尸体硬脑膜移植相关。 1987年5月之前,德国制造商生产的单个硬脑膜移植物品牌(Lyodura)被确定为除一种情况外最有可能传播的媒介。到2003年,日本的持续监视共发现了97起此类案件。此后,又发现了35例。该报告更新了以前的报告,并总结了迄今为止与硬脑膜移植相关的所有132例病例的调查。结果表明,由于接受移植物和症状发作之间的潜伏期较长(可能> 24.8年),在日本继续监测可能会发现与硬脑膜移植物相关的其他CJD病例。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号